AIMCA
PNT

Alberta Investment Management Corp (AIMCo)’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,018
Closed -$190K – 1227
2023
Q2 		$190K Hold
21,018
– – ﹤0.01% 1149
2023
Q1 		$153K Sell
21,018
-5,326
-20% -$39.5K ﹤0.01% 1187
2022
Q4 		$192K Sell
26,344
-1,158
-4% -$8.59K ﹤0.01% 1012
2022
Q3 		$213K Buy
+27,502
New +$233K ﹤0.01% 1158

Other funds holding PNT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s PNT Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2023, closing a stake of 21,018 shares — an estimated $190K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in PNT in Q3 2022 and held it in 4 quarters. The position peaked at $213K in Q3 2022. 125 funds tracked by Wall St. Rank hold PNT as of Q3 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 21,018 POINT Biopharma Global Inc. Common Stock shares in Q3 2023, an estimated $190K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Alberta Investment Management Corp (AIMCo)'s POINT Biopharma Global Inc. Common Stock position peaked at $213K in Q3 2022.
  • 125 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.